WWW.FRO.BE


>> Publicatielijst A-G

THE PURPOSE OF RESEARCH IS TO INCREASE OUR INSIGHT IN FUNCTION AND DYSFUNCTION OF THE VISUAL SYSTEM


List of Papers by Laureates of FRO (Oct 2005) (A t/m G)


BALI Ernesto

1. De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-5

2. Bali E., Huyghe P., Caspers L. and Libert J. (2003). Vitrectomy and silicone oil in the treatment of acute endophthalmitis. Bull. Soc. belge Ophtalmol. 288, 9-14

3. Bali E., Willermain F., Caspers-Velu L., Dubois C., Dehou M.F., Velu T., Libert J. and Bruyns C. (2003). IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy. Int. J. Mol. Med. 12 (3), 305-310


BOUSSERY Koen

1. Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560

2. Van de Voorde J., Boussery K. and Vanheel B. (2001). Role of the endothelium in the vasorelaxing effect of histamine on rat isolated gastric small arteries. Inflamm. Res. 50 (Suppl. 2), S120-121

3. Boussery K., Franki A.S., Delaey C. and Van de Voorde J. (2002). A vasorelaxing factor is released form mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177

4. Mitamura M., Boussery K., Horie S., Murayama T. and Van de Voorde J. (2002). Vasorelaxing effect of mesaconitine, an alkaloid from Aconitum japonicum, on rat small gastric artery: possible involvement of endothelium-derived hyperpolarizing factor. Jpn. J. Pharmacol. 89 (4), 380-387

5. Boussery K., Delaey C. and Van de Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286

6. Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248

7. De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2003). Potassium potently relaxes small rat skeletal muscle arteries. Med. Sci. Sports Exerc. 35 (12), 2005-2012

8. Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559

9. De Clerck I., Boussery K., Pannier J.L. and Van de Voorde J. (2005). Hyperosmolarity increase K+-induced vasodilations in rat skeletal muscle arterioles. Med. Sci. Sports Exerc. 37 (2), 220-226

10. Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427

11. Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146

12. Peeters L., Sanders N.N., Braeckmans K., Boussery K., Van de Voorde J., De Smedt S.C. and Demeester J. (2005). Vitreous: a barrier to non-viral ocular gene therapy. Invest. Ophthalmol. Vis. Sci. 46 (10), 3553-3561


CABAY Laurence

1. Cabay J.E., Boverie J.H. and Dondelinger R.F. (1998). Percutaneous catheter drainage of external fistulas of the pancreatic ducts. Eur. Radiol. 8 (3), 445-8

2. Cabay L., Willermain F., Bruyns C., Verdebout J.M., Witta Y., Baffi J., Velu T., Libert J., Caspers-Velu L., Maho A. and Lespagnard L. (2003). CXCR4 expression in vitreoretinal membranes. Br. J. Ophthalmol. 87 (5), 567-569


CLAERHOUT Ilse

1. Claerhout I. and Kestelyn P. (1999). Acanthamoeba keratitis: a review. Bull. Soc. belge Ophtalmol. 274, 71-82

2. Beele H., Claerhout I., Kestelyn P., Dierckxens L., Nayaert J.M. and De Laey J.J. (2001). Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatol. 202 (2), 147-150

3. Claerhout I., Beele H., Verstraete A., Van den Broecke C. and Kestelyn P. (2001). The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model. Graefes Arch. Clin. Exp. Ophthalmol. 239 (2), 152-157

4. Claerhout I., Beele H., Van den Abeele K. and Kestelyn P. (2002). Therapeutic penetrating keratoplasty: clinical outcome and evolution of endothelial cell denstity. Cornea. 21 (7), 637-642

5. Boonstra F., Claerhout I., Hol F., Smit G., van Collenburg V. and Meire F. (2002). Corneal decompensation in a boy with Kearns-Sayre syndrome. Ophthalmic Genet. 87 (5), 247-251

6. Sinnaeve B.A., Decaestecker T.N., Claerhout I.J., Kestelyn P., Remon J.P. and Van Bocxlaer J.F. (2003). Confirmation of ofloxacin precipitation in corneal deposits by microbore liquid chromatography-quadrupole time-of-flight tandem mass spectrometry. J. Chromatogr. B. Analyt. Biomed. Life Sci. 785 (1), 193-196

7. Claerhout I. (2003). Corneal opacification following keratoplasty in the rat model. Br. J. Ophthalmol. 87 (2), 249-250

8. Claerhout I., Kestelyn P., Meire F., Remon J.P., Decaestecker T. and Van Bocxlaer J. (2003). Corneal deposits after the topical use of ofloxacin in two children with vernal keratoconjunctivitis. Br. J. Ophthalmol. 87 (5), 646

9. Claerhout I., Beele H., De Bacquer D. and Kestelyn P. (2003). Factors influencing the decline in endothelial cell density after corneal allograft rejection. Invest. Ophthalmol. Vis. Sci. 44 (11), 4747-4752

10. Goegebuer A., Ajay L., Claerhout I. and Kestelyn P. (2003). Results of penetrating keratoplasty in syphilitic interstitial keratitis. Bull. Soc. belge Ophtalmol. 290, 35-39

11. Claerhout I., Kestelyn P., Debacker V., Beele H. and Leclercq G. (2004). Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation. 77 (5), 676-682

12. Claerhout I., Goegebuer A., Van Den Broecke C. and Kestelyn P. (2004). Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch. Clin. Exp. Ophthalmol. 242 (8), 648-653

13. Claerhout I. and Kestelyn P. (2004). Results of penetrating keratoplasty in syphilitic interstitial keratitis (French). Rev. belge Med. Dent. 59 (1), 34-42


CLAES Catherine

1. De Graeve C., Van de Sompel W. and Claes C. (1999). Ocular ischemic syndrome: two case reports of bilateral involvement. Bull. Soc. belge Ophtalmol. 273, 69-74

2. Dorchy H., Claes C. and Verougstraete C. (2002). Risk Factors of Developing Proliferative Retinopathy in Type 1 Diabetic Patients: Role of BMI. Diabetes Care. 4, 798-799

3. Lambert V., Munaut C., Carmeliet P., Gerard R.D., Declerck P.J., Gils A., Claes C., Foidart J.M., Noel A. and Rakic J.M. (2003). Dose-dependent modulation of choroidal neovascularisation by plasminogen activator inhibitor type I: implications for clinical trials. Invest. Ophthalmol. Vis. Sci. 44 (6), 2791-2797

4. Rakic J.M., Lambert V., Devy L., Luttun A., Carmeliet P., Claes C., Nguyen L., Foidart J.M., Noel A. and Munaut C. (2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularisation. Invest. Ophthalmol. Vis. Sci. 44 (7), 3186-3193

5. Geerts L., Pertile G., Van de Sompel W., Moreels T. and Claes C. (2004). Vitrectomy for epiretinal membranes: visual outcome and prognostic criteria. Bull. Soc. belge Ophtalmol. 293, 7-15

6. Demols P., Claes C.A., Farber C.M. and Rasquin F. (2004). Macular CMV retinitis: a case report. Bull. Soc. belge Ophtalmol. 293, 17-21


COOLS Doris

1. Cools D., Debiec-Rychter M., Parys-Van Ginderdeuren R., Hagemeijer-Hausman A., Van den Oord J. and Spileers W. (2000). Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Bull. Soc. belge Ophtalmol. 278, 67-70


DE BAERE Elvire

1. De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of the cellular retinol-binding protein 1 gene (RBP1) and of the coatomer beta subunit gene (COPB2) to human chromosome band 3q23 by in situhybridization. Cytogenet. Cell. Genet. 82 (3-4), 226-227

2.De Baere E., Speleman F., Van Roy N., De Paepe A. and Messiaen L. (1998). Assignment of SHOX2 (alias OG12X and SHOT) to human chromosome bands 3q25-q26.1 by in situ hybridization. Cytogenet. Cell. Genet. 82 (3-4), 228-229

3.De Baere E., Van Roy N., Speleman F., Fukushima Y., De Paepe A. and Messiaen L. (1999). Closing in on the BPES gene on 3q2- mapping of a de novo reciprocal translocation t(3;4)(q23;p15.2) breakpoint within a 45-kb cosmid and mapping of three candidate genes, RBP1, RBP2 and beta'-COP, distal to the breakpoint. Genomics. 57 (1), 70-78

4. De Baere E., Fukushima Y., Small K., Udar N., Van Camp G., Verhoeven K., Palotie A., De Paepe A. and Messiaen L. (2000). Identification of BPESC1, a novel gene disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES. Genomics. 68 (3), 296-304

5. Gross C., De Baere E., Lo A., Chang W. and Messiaen L. (2001). Cloning and characterization of human WDR10, a novel gene located at 3q21 encoding a WD-repeat protein that is highly expressed in pituitary and testis. DNA Cell Biol. 20 (1), 41-52

6. De Baere E., Dixon M.J., Small K.W., Jabs E.W., Leroy B.P., Devriendt K., Gillerot Y., Mortier G., Meire F., Van Maldergem L., Courtens W., Hjalgrim H., Huang S., Liebaers I., Van Regemorter N., Touraine P., Praphanphoj V., Verloes A., Udar N., Yellore V., Chalukya M., Yelchits S., De Paepe A., Kuttenn F., Fellous M., Veitia R. and Messiaen L. (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum. Molec. Genet. 10 (15), 1591-1600

7. De Baere E., Lemercier B., Christin-Maitre S., Durval D., Messiaen L., Fellous M. and Veitia R. (2002). FOXL2 mutation screening in a large panel of POF patients and XX males. J. Med. Genet. 39 (8), 43

8. Cocquet J., Pailhoux E., Jaubert F., Servel N., Xia X., Pannetier M., De Baere E., Messiaen L., Cotinot C., Fellous M. and Veitia R. (2002). Evolution and expression of FOXL2. J. Med. Genet. 39 (12), 916-921

9. De Baere E., Beysen D., Oley C., Lorenz B., Cocquet J., De Sutter P., Devriendt K., Dixon M., Fellous M., Fryns J.P., Garza A., Jonsrud C., Koivisto P.A., Krause A., Leroy B.P., Meire F., Plomp A., Van Maldergem L., De Paepe A., Veitia R. and Messiaen L. (2003). FOXL2 and BPES: mutational hotspots, phenotypic variability and revision of the genotype-phenotype correlation. Am. J. Hum. Genet. 72 (2), 478-487

10. Cocquet J., De Baere E., Caburet S. and Veitia R. (2003). Compositional biases and polyalanine runs in humans. Genetics. 165 (3), 1613-1617

11. Cocquet J., De Baere E., Gareil M., Pannetier M., Xia X., Fellous M. and Veitia R.A. (2003). Structure, evolution and expression of the FOXL2 transcription unit (review). Cytogenet. Genome Res. 101 (3-4), 206-211

12. Beysen D., Vandesompele J., Messiaen L., De Paepe A. and De Baere E. (2004). The human FOXL2 mutation database. Hum. Mutat. 24 (3), 189-193

13. Caburet S., Demarez A., Moumne L., Fellous M., De Baere E. and Veitia R.A. (2004). A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation. J. Med. Genet. 41 (12), 932-936

14. Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., Fryns J.P., Kim J.R., Lapunzina P., Lemyre E., Meire F., Messiaen L.M., Oley C., Splitt M., Thomson J., Peer Y.V., Veitia R.A., De Paepe A. and De Baere E. (2005). Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharochimosis syndrome. Am. J. Hum. Genet. 77 (2), 205-218


DE JONG Casper

1. De Jong C., Bali E., Libert J. and Caspers-Velu L. (2000). ADCON-L hydrogel as a vitreous substitute: preliminary results. Bull. Soc. belge Ophtalmol. 278, 71-75


DE KEYZER Katrien

1. De Keyzer K. and Tassignon M.J. (2004). Case report: acute unilateral loss of visual acuity after a visit to the dentist: an unusual complication after the use of an anesthetic combined with adrenaline (French). Rev. belge Med. Dent. 59 (1), 30-33


DELAEY Christophe

1. Delaey C. and Van de Voorde J. (1995). Prostanoid-induced contractions are blocked by sulfonylureas. Eur. J. Pharmacol. 280 (2), 179-184

2. Delaey C. and Van de Voorde J. (1997). Heterogeneity of the inhibitory influence of sulfonylureas on prostanoid-induced smooth muscle contraction. Eur. J. Pharmacol. 325 (1), 41-46

3. Van de Voorde J., Delaey C, Depypere H. and Vanheel B. (1998). Mechanisms involved in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Eur. J. Pharmacol. 349 (1), 61-66

4. Delaey C. and Van de Voorde J. (1998). The effect of NO donors on bovine retinal small arteries and posterior ciliary arteries. Invest. Ophthalmol. Vis. Sci. 39 (9), 1642-1646

5. Delaey C. and Van de Voorde J. (1998). Retinal arterial tone is controlled by a retinal-derived relaxing factor. Circ. Res. 83 (7), 714-720

6. Van de Voorde J., Delaey C., Depypere H. and Vanheel B. (1999). Role of the endothelium in the vasorelaxing influence of histamine on isolated human subcutaneous resistance arteries. Inflamm. Res. 48 (Suppl. 1), S100-101

7. Delaey C. and Van de Voorde J. (2000). Pressure-induced myogenic responses in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (7), 1871-1875

8. Delaey C., Boussery K. and Van de Voorde J. (2000). A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries. Invest. Ophthalmol. Vis. Sci. 41 (11), 3555-3560

9. Delaey C. and Van De Voorde J. (2000). Regulatory mechanisms in the retinal and choroidal circulation (review). Ophthalmic Res. 32 (6), 249-256

10. Delaey C. (2001). Retinal tissue modulates retinal arterial tone through the release of a potent vasodilating factor. Verh. K. Acad. Geneeskd. Belg. 63 (4), 335-357

11. Boussery K., Franki A.S., Delaey C. and Van De Voorde J. (2002). A vasorelaxing factor is released from mouse retinal tissue. Ophthalmic Res. 34 (3), 172-177

12. Boussery K., Delaey C. and Van De Voorde J. (2002). Rat retinal tissue releases a vasorelaxing factor. Invest. Ophthalmol. Vis. Sci. 43 (10), 3279-3286

13. Delaey C., Boussery K. and Van de Voorde J. (2002). Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation. Exp. Eye Res. 75 (3), 243-248

14. Boussery K., Delaey C. and Van de Voorde J. (2004). Influence of adrenomedullin on tone of isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 45 (2), 552-559

15. Boussery K., Delaey C. and Van de Voorde J. (2005). The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries. Invest. Ophthalmol. Vis. Sci. 46 (4), 1420-1427

16. Boussery K., Lambrecht S., Delaey C. and Van de Voorde J. (2005). Clozapine directly relaxes bovine retinal arteries. Curr. Eye Res. 30 (2), 139-146


DENYS Katrien

1. Vanduffel W., Fize D., Peuskens H., Denys K., Sunaert S., Todd J.T. and Orban G.A. (2002). Extracting 3D from motion: differences in human and monkey intraparietal cortex. Science. 298 (5592), 413-415

2. Fize D., Vanduffel W., Nelissen K., Denys K., Chef d'Hotel C., Faugeras O. and Orban G.A. (2003). The retinotopic organization of primate dorsal V4 and surrounding areas: a functional magnetic resonance imaging study in awake monkeys. J. Neurosci. 23 (19), 7395-7406

3. Orban G.A., Fize D., Peuskens H., Denys K., Nelissen K., Sunaert S., Todd J. and Vanduffel W. (2003). Similarities and differences in motion processing between the human and macaque brain: evidence from fMRI. Neuropsychologia 41 (13), 1757-1768

4. Denys K., Vanduffel W., Fize D., Nelissen K., Peuskens H., Van Essen D. and Orban G.A. (2004). The processing of visual shape in the cerebral cortex of human and non-human primates: a functional magnetic resonance imaging study. J. Neurosci. 24 (10), 2551-2565

5. Denys K., Vanduffel W., Fize D., Nelissen K., Sawamura H., Georgieva S., Vogels R., Van Essen D. and Orban G.A. (2004). Visual activation in prefrontal cortex is stronger in monkeys than in humans. J. Cogn. Neurosci. 16 (9), 1505-1516


DILLEN Kathleen

1. Dillen K., Vandervoort J., Van den Mooter G., Verheyden L. and Ludwig A. (2004). Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles. Int. J. Pharm. 275 (1-2), 171-187

2. Dillen K., Weyenberg W., Vandervoort J. and Ludwig A. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. Eur. J. Pharm. Biopharm. 58 (3), 539-549

3. Dillen K., Vandervoort J. and Ludwig A. (2005). Factorial design, physicochemical characterisation and activity of ciprofloxacin-loaded PLGA nanoparticles for ocular use. J. Control Release 101 (1-3), 369-371

4. Bozdag S., Dillen K., Vandervoort J. and Ludwig A. (2005). The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles. J. Pharm. Pharmacol. 57 (6), 699-707


DUCHESNE Bernard

1. Comhaire-Poutchinian Y., Duchesne B. and Ries M. (1993). The value of MRI in a difficult diagnosis of melanoma of the choroid (French). Bull. Soc. belge Ophtalmol. 248, 47-51

2. Marechal-Courtois C. and Duchesne B. (1993). Recurrent corneal erosion (French). Bull. Soc. belge Ophtalmol. 247 (1), 13-15

3. Duchesne B. (1993). HLA typing and corneal grafts (French). Bull. Soc. belge Ophtalmol. 247 (1), 29-32

4. Duchesne B., Marechal-Courtois C. and Melin P. (1994). A case of keratitis due to Mycobacterium chelonae (French) (review). Bull. Soc. belge Ophtalmol. 254, 59-62

5. Locht B., Janssens M., Duchesne B. and Bonnet S. (1995). Normovolemic hemodilution in central retinal vein thrombosis: personal experience apropos of 14 cases (French). Bull. Soc. belge Ophthalmol. 259, 89-92

6. Comhaire-Poutchinian Y., Duchesne B., Collignon J., Ries M. (1996). Magnetic resonance imaging in the diagnosis of doubtful cases of small melanoma of the choroid (French). J. Fr. Ophtalmol. 19 (2), 111-119

7. Joachim M., Andris C., Duchesne B. (1996). Pharma-clinics. How I treat ... thyroid ophthalmopathy (French). Rev. Med. Liège. 51 (7), 449-452

8. Tahi H., Kondo H., Duchesne B., Lee W., Feuer W. and Parel J.M. (1998). Gel injection adjustable keratoplasty (GIAK): keratometric evaluation on cadaver eyes (French). Bull. Soc. belge Ophtalmol. 268, 13-17

9. Duchesne B., Tahi H., Gautier S., Jallet V., Villain F., Parel J.M. (1998). Implantation of controlled-release 5-FU for the prevention of secondary cataract: preliminary study (French). Bull. Soc. belge Ophtalmol. 268, 69-72

10. Duchesne B., Mans B., Lavalley B., Gerard C., Marechal-Courtois C., Betz P. and Tseng S.C. (1998). Use of the cryopreserved human amniotic membrane for reconstruction of the ocular surface (French). Bull. Soc. belge Ophtalmol. 268, 73-77

11. Claes E., Duchesne B., Lavalleye B., Lejeune T., Delcourt J.C., Bouillenne C. and Marechal-Courtois C. (1998). Types of corneal transplantation: experience and review (French). Bull. Soc. belge Ophtalmol. 268, 87-92

12. Tahi H., Duchesne B., Parel J.M., Nose I., Denham D., Villain F. and Lacombe E. (1998). Keratoprosthesis by posterior fixation and mechanical biocompatibility: determination of intraocular pressure provoking aqueous humor leak and/or extrusion (French). Bull. Soc. belge Ophtalmol. 268, 87-92

13. Carrette S., Marechal-Courtois C., Hernandez J., Hayette M.P., Deprez M. and Duchesne B. (2000). Report of a case of Acanthamoeba keratitis (French). Bull. Soc. belge Ophtalmol. 275, 49-53

14. Duchesne B., Tahi H. and Galand A. (2001). Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea. 20 (2), 230-232

15. Hamaoui M., Tahi H., Chapon P., Duchesne B., Fantes F., Feuer W. and Parel J.M. (2001). Corneal preparation of eye bank eyes for experimental surgery. Cornea. 20 (3), 317-320

16. Hick S., Duchesne B., Kaye O., Marechal-Courtois C. and Galand A. (2002). Corneal ulcers associated with rheumatoid arthritis (French). Rev. Med. Liège. 57 (4), 228-232

17. Barile P., Leroy C., Bolle S., Arrese J.E., Hermanns-Le T., Pierard G.E. and Duchesne B. (2004). Merkel cell carcinoma (French). J. Fr. Ophtalmol. 27 (4), 432-436

18. Blaise P., Duchateau E., Duchesne B., Comhaire Y. and Rakic J.M. (2004). Retinal vascular occlusions: diagnosis and management (French). Rev. Med. Interne. 25 (12), 881-890

19. Hick S., Demers P.E., Brunette I., La C., Mabon M. and Duchesne B. (2005). Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea. 24 (4), 369-377


FOLLENS Ingrid

1. Van Overmeire B., Follens I., Hartmann S., Creten W.L. and Van Acker K.J. (1997). Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child Fetal Neonatal Ed. 76 (3), F179-184

2. Follens I., Godts D., Evens P.A. and Tassignon M.J. (2001). Combined fourth and sixth cranial nerve palsy after lumbar puncture: a rare complication. A case report. Bull. Soc. belge Ophtalmol. 281, 29-33

3. Van Kerckhoven W., Lafaut B., Follens I. and De Laey J.J. (2001). Features of age-related macular degeneration on optical coherence tomography. Bull. Soc. belge Ophtalmol. 281, 75-84


You can find this text at FRO
http://www.fro.be

The URL is:
http://www.fro.be/index.php?op=content&id=26